Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20

Name: A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20 — clinical trial record (NCT07792941)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorPfizer

Started2026-08-27

View on ClinicalTrials.gov ↗

This study aims to learn how the body handles tilrekimig when given with another medicine called recombinant human hyaluronidase PH20 (rHuPH20). rHuPH20 is approved to help some medicines be taken up by the body when they are given together as an injection (shot) under the skin.

Amendment history 1 change detected by DataLookout

2026-09-05

Recruitment opened

Trial Details

NCT Number	NCT07792941
Lead Sponsor	Pfizer
Conditions	Healthy
Enrollment	12 participants
Start Date	2026-08-27
Primary Completion	2027-02-11 (estimated)
Study Completion	2027-02-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-04